Gerresheimer (GRRMF) Stock Price, News & Analysis

Company Overview

Gerresheimer AG is a Germany-based manufacturer of packaging and drug-delivery systems for the pharmaceutical, biotechnology and cosmetics industries. The company develops and produces glass and plastic packaging, including vials, ampoules, syringes, cartridges, bottles and other containers used to store and administer medicines and other sensitive products.

Its portfolio also includes medical devices and drug-delivery solutions such as prefillable syringes, inhalers, pens and other injection-related systems. Gerresheimer works with pharmaceutical and biotechnology companies on product development, industrial manufacturing and packaging solutions designed to support the safe and efficient delivery of medicines.

Founded in 1864, Gerresheimer is headquartered in Düsseldorf, Germany, and serves customers internationally through production and operating locations across Europe, North America, South America and Asia. The company’s shares trade in Germany, while its American depositary interests are also quoted over the counter under the symbol GRRMF.

Key Stats

• Today's Range: $29.05 to $29.05
• 50-Day Range: $29.05 to $32.20
• 52-Week Range: $19.17 to $33.35
• Volume: N/A
• Average Volume: 244 shs
• Market Capitalization: N/A
• P/E Ratio: 12.80
• Dividend Yield: 1.78%
• Price Target: N/A
• Consensus Rating: Reduce

Gerresheimer Stock Analysis - MarketRank™

Gerresheimer scored higher than 15% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.3 / 5
• Analyst Rating: Reduce

Consensus Rating

Gerresheimer has received a consensus rating of Reduce. The company's average rating score is 1.80, and is based on no strong buy ratings, no buy ratings, 4 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Gerresheimer has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Gerresheimer is 12.80, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 40.88.

Price to Earnings Ratio vs. Sector

The P/E ratio of Gerresheimer is 12.80, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 198.77.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Gerresheimer has a short interest ratio ("days to cover") of 999.99, which indicates bearish sentiment.

Change versus previous month

Short interest in Gerresheimer has recently decreased by 3.06%, indicating that investor sentiment is improving.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Gerresheimer pays a meaningful dividend of 1.30%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Gerresheimer does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Gerresheimer is 22.82%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: N/A
• News Sentiment: N/A

Company Ownership

• Score: 0.6 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Gerresheimer insiders have not sold or bought any company stock.

Percentage Held by Institutions

53.23% of the stock of Gerresheimer is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Today: 10/14/2026
• Next Earnings (Estimated): 11/04/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:GRRMF
• CIK: N/A
• Web: www.gerresheimer.com
• Phone: 49 211 6181 00
• Fax: N/A
• Employees: 11,947
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 12.80
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A